DividendInvestor.com

First In Dividend Data Worldwide®

DIVIDEND ANNOUNCEMENT: Sr Nt/Harrow Health Inc (NASDAQ:HROWM) on 07/05/2023 declared a dividend of $0.7422 per share

July 05, 2023

Sr Nt/Harrow Health Inc (NASDAQ:HROWM) on 07/05/2023 declared a dividend of $ 0.7422 per share payable on July 31, 2023 to shareholders of record as of July 15, 2023.

Sr Nt/Harrow Health Inc (NASDAQ:HROWM) has paid dividends since 2023, has a current dividend yield of 11.7390842438% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 25.30 and has a 52 week low/high of $ 23.55 and $ 25.53.

Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures.

For more information on Sr Nt/Harrow Health Inc click here.

Sr Nt/Harrow Health Inc current dividend information as per the date of this press release is:
Dividend Declaration Date: July 05, 2023
Dividend Ex Date: July 13, 2023
Dividend Record Date: July 15, 2023
Dividend Payment Date: July 31, 2023
Dividend Amount: $ 0.7422
 
 

DividendInvestor.com

DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.

Contact:
info@DividendInvestor.com

X
Search Dividend Investor